Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 1.00 |
| ▸ | HSD11B1 | P28845 | 5/20 | 0.70 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.70 |
| ▸ | F10 | P00742 | 3/20 | 0.57 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.57 |
| ▸ | CDC25B | P30305 | 1/20 | 0.57 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Kaurenoic Acid SCHEMBL29626999 | 1.00 | PTPN1 (1.00) | PTPN1HSD11B1HSD11B2F10PTPN2 | |
| Kaurenoic Acid SCHEMBL3489848 | 1.00 | PTPN1 (1.00) | PTPN1HSD11B1HSD11B2F10PTPN2 | |
| Kaurenoic Acid SCHEMBL31238213 | 1.00 | PTPN1 (1.00) | PTPN1HSD11B1HSD11B2F10PTPN2 | |
| Kaurenoic Acid SCHEMBL13401813 | 1.00 | PTPN1 (1.00) | PTPN1HSD11B1HSD11B2F10PTPN2 | |
| Kaurenoic Acid SCHEMBL13464128 | 1.00 | PTPN1 (1.00) | PTPN1HSD11B1HSD11B2F10PTPN2 | |
| Kaurenoic Acid SCHEMBL1921625 | 1.00 | PTPN1 (1.00) | PTPN1HSD11B1HSD11B2F10PTPN2 | |
| Kaurenoic Acid SCHEMBL18073589 | 1.00 | PTPN1 (1.00) | PTPN1HSD11B1HSD11B2F10PTPN2 | |
| Kaurenoic Acid SCHEMBL262426 | 1.00 | PTPN1 (1.00) | PTPN1HSD11B1HSD11B2F10PTPN2 | |
| Kaurenoic Acid SCHEMBL21803663 | 1.00 | PTPN1 (1.00) | PTPN1HSD11B1HSD11B2F10PTPN2 | |
| Kaurenoic Acid SCHEMBL262427 | 1.00 | PTPN1 (1.00) | PTPN1HSD11B1HSD11B2F10PTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8133915-B2 | Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators | NEREUS PHARMACEUTICALS, INC. (US) | 2012-03-13 | — | — | US | disclosed |
| US-20110160309-A1 | INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-ALPHA MODULATORS; SYNTHESES OF SUCH MODULATORS AND METHODS OF USING SUCH MODULATORS | NEREUS PHARMACEUTICALS, INC. (US) | 2011-06-30 | — | — | US | disclosed |
| US-7893299-B2 | Acanthoic amide derivatives; inflammation, cancer, cachexia, cardiovascular disease, infections, diabetes, otitis media, sinusitis, transplant rejection | NEREUS PHARMACEUTICALS, INC. (US) | 2011-02-22 | — | — | US | disclosed |
| US-20080271205-A1 | Method for producing steviol synthetase gene and steviol | RIKEN | 2008-10-30 | — | — | US | disclosed |
| US-20080064753-A1 | Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators | HENSLER, MARY | 2008-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160309-A1 | INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-ALPHA MODULATORS; SYNTHESES OF SUCH MODULATORS AND METHODS OF USING SUCH MODULATORS | IL1A, IL1B, TNF | PTPN1 2008/4885HSD11B1 720/4885HSD11B2 1528/4885 |
| US-20080064753-A1 | Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators | IL1A, IL1B, TNF | PTPN1 2008/4885HSD11B1 720/4885HSD11B2 1528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.